1-butyl-3-methylimidazolium dihydrogen phosphate

We are 1-butyl-3-methylimidazolium dihydrogen phosphate CAS:C8H17N2O4P manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


English Name: 1-butyl-3-methylimidazolium dihydrogen phosphate
Synonyms:1-butyl-3-methylimidazolium dihydrogen phosphate
Molecular Formula: C8H17N2O4P
Molecular Weight: 236.21
CAS No.: C8H17N2O4P
Purity: 98%
 
Technical Information

Appearance:	Purity:
NMR: Passed	null
Solubility:	Insolubility:
Impurity content: (1) Methylimidazole content: < 1000 ppm; (2) Halogen content: < 1000 ppm; (3) Water content: < 1000 ppm

 
Physics-Chemistry Properties

Melting point:	Decomposition temperature:
Conductivity:	Electrochemical window:
Viscosity:	Density:

 
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts



Related News: The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.1693-28-3 In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.100331-89-3 But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US.127-17-3 ICIG is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses.The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.